mRNA is transformational
With our technology, we are revolutionizing medicine and developing potential mRNA treatments in shorter periods of time for previously untreatable and emerging diseases.
We can positively impact the lives of millions of people
Our mRNA platform, with its speed, scale, and flexibility, is uniquely suited to tackle current and emerging pathogens that threaten global health.
Our Research Engine
Our Research Engine combines proprietary digital drug design tools and a highly automated production facility to enable Moderna to advance mRNA vaccines and therapeutics.
Scientists can select any protein in the human proteome to be engineered or they can design novel proteins. All can be designed to explore previously undiscovered pathways.
mRNA early development engine
Across our internally developed and partnered mRNA programs, we are simultaneously advancing mRNA development candidates for many diseases into and through clinical studies.
Our mRNA EARLY DEVELOPMENT ENGINE™ services combine internal and external capabilities for process development, toxicology studies, global regulatory interactions, and clinical study preparation and execution for our mRNA vaccines and therapeutics.
These services are designed to deliver many investigational mRNA vaccines and therapeutics to human proof of concept data.